
Research
Areas of Study

Melanoma Risk
Cust et al, 2020, A risk prediction model for the development of subsequent primary melanoma in a population-based cohort (PMID 31520533)
Yardman-Frank et al, 2021, Differences in Melanoma Between Canada and New South Wales, Australia: A Population-Based Genes, Environment, and Melanoma (GEM) Study (PMID 33768212)

Pathoepidemiology & Molecular Pathoepidemiology
Thomas et al, 2013, Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study (PMID 24127443)
Yardman-Frank et al, 2021, Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma (PMID 34409386)

Melanoma Survival
Taylor et al, 2016, Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma (PMID 27101944)
Murali et al, 2025, Sex differences in melanoma survival: a GEM study (PMID 39799507)

Communication & Behavioral Risk Reduction
Zapolska et al, 2016, Patterns and sources of information about family melanoma risk among melanoma survivors (PMID 30190879)
Hay et al, 2024, Exploring the role of cancer fatalism and engagement with skin cancer genetic information in diverse primary care patients (PMID 38546209)

Methodological
Vicory et al, 2015, Appearance normalization of histology slides (PMID 25863518)
Mauguen et al, 2017, Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma (PMID 28603323)
Grants and Awards
A model for genetic susceptibility: melanoma
U01 CA83180-01 NIH (Berwick)
Solar exposure and melanoma survival
R01 CA112524 NIH (Berwick)
Mutational analysis of clonality in multiple primary melanoma
R03 CA125829 NIH (Orlow)
Melanoma RAS/BRAF mutation: heterogeneity-risk-prognosis
R01 CA112243 NIH/NC (Thomas)
Validation of the use of whole-genome amplified DNA in a population-based study
R03 CA173806 NIH/NCI (Orlow)
Identification of Lethal Melanoma at the Time of Diagnosis
*R01 CA233524 NIH/NCI (Thomas, Begg, Berwick)
*current support
Epi Questionnaire
Access the GEM study Epidemiological Questionnaire